Latest filing published 05 Sept 2023 for Surgalign Holdings, INC., €20.
No signal scores available.
Paolo Amoruso appears in our data through filings on Surgalign Holdings, Inc. shares, published by SEC (Form 4). In total, 2 filings cover trades dated from 1 September 2022 to 1 September 2023.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The newest entry dates from 5 September 2023: a share grant of €20, in Surgalign Holdings, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations